Table 2.
Comparison of genotype distribution and allele frequency among the control group, the NAFLD group, and the NAFLD+CAD group.
| Groups | Control n = 149 |
NAFLD n = 113 |
CAD+NAFLD n = 75 |
χ 2 | P | |
|---|---|---|---|---|---|---|
| Genotypes (%) | T/T | 75 (50.03) | 58 (51.32) | 44 (58.67) | 2.459 | 0.652 |
| T/del | 65 (43.62) | 46 (40.71) | 25 (33.33) | |||
| del/del | 9 (6.04) | 9 (7.96) | 6 (8.00) | |||
| Alleles (%) | T | 215 (72.15) | 162 (71.68) | 113 (75.33) | 0.688 | 0.709 |
| del | 83 (27.85) | 64 (28.32) | 37 (24.67) |
Control: healthy control; NAFLD: nonalcoholic fatty liver disease; NAFLD+CAD: NAFLD patients with coronary artery disease.